• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Prognostic factors among 130 patients with osteosarcoma.

作者信息

Pochanugool L, Subhadharaphandou T, Dhanachai M, Hathirat P, Sangthawan D, Pirabul R, Onsanit S, Pornpipatpong N

机构信息

Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.

出版信息

Clin Orthop Relat Res. 1997 Dec(345):206-14.

PMID:9418642
Abstract

One hundred thirty patients with high grade osteosarcoma were enrolled in a randomized prospective multidisciplinary treatment that included intraarterial chemotherapy, local irradiation, limb salvage surgery, and prophylactic whole lung irradiation. The patients were evaluated to stage the prognostic factors. In a multivariate analysis, a minimal level of serum lactic acid dehydrogenase less than 300 IU/L showed a significant prognostic value. The history of trauma before diagnosis of disease, local irradiation of the affected site, histologic response to preoperative multidisciplinary therapy, and prophylactic whole lung irradiation were associated with significantly better prognosis in the log rank test. Patient age, site of the primary tumor, presentation of fracture, pathologic subtype, signs and symptoms, serum alkaline phosphatase level, and erythrocyte sedimentation rate were not found to be prognostic factors. The 9-year survival rate of the whole group was 55%.

摘要

相似文献

1
Prognostic factors among 130 patients with osteosarcoma.
Clin Orthop Relat Res. 1997 Dec(345):206-14.
2
Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy: 15-year experience in 789 patients treated at a single institution.新辅助化疗治疗肢体骨肉瘤的预后因素:单机构789例患者的15年经验
Cancer. 2006 Mar 1;106(5):1154-61. doi: 10.1002/cncr.21724.
3
Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols.原发性转移性骨肉瘤:接受新辅助骨肉瘤协作研究组方案治疗患者的表现及预后
J Clin Oncol. 2003 May 15;21(10):2011-8. doi: 10.1200/JCO.2003.08.132.
4
[Primary chemotherapy with the Rosen T10 protocol before conservative surgery in limb primitive osteosarcomas: results about 56 cases].肢体原发性骨肉瘤保肢手术前采用罗森T10方案进行初始化疗:56例病例结果
Bull Cancer. 2000 Feb;87(2):183-8.
5
[Prognostic factors for the local recurrence of osteosarcoma in extremities treated with combined therapy].[肢体骨肉瘤联合治疗后局部复发的预后因素]
Zhonghua Wai Ke Za Zhi. 2007 Aug 15;45(16):1114-7.
6
Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS).综合治疗后骨肉瘤复发:对骨肉瘤协作研究组(COSS)中未经挑选患者的分析。
J Clin Oncol. 2005 Jan 20;23(3):559-68. doi: 10.1200/JCO.2005.04.063.
7
Pattern of disease recurrence and prognostic factors in patients with osteosarcoma treated with contemporary chemotherapy.接受现代化疗的骨肉瘤患者的疾病复发模式及预后因素
Cancer. 2003 Dec 1;98(11):2447-56. doi: 10.1002/cncr.11799.
8
Metastatic osteosarcoma at diagnosis: prognostic factors and long-term outcome--the French pediatric experience.诊断时的转移性骨肉瘤:预后因素及长期结局——法国儿科经验
Cancer. 2005 Sep 1;104(5):1100-9. doi: 10.1002/cncr.21263.
9
[The prognostic significance of tumor volume in osteosarcoma with neoadjuvant chemotherapy].[新辅助化疗后骨肉瘤肿瘤体积的预后意义]
Klin Padiatr. 1993 Jul-Aug;205(4):200-9. doi: 10.1055/s-2007-1025228.
10
Long-term outcome after polychemotherapy and intensive local radiation therapy of high-grade osteosarcoma.高分级骨肉瘤多药化疗及强化局部放射治疗后的长期疗效
Eur J Cancer. 2009 Sep;45(14):2447-51. doi: 10.1016/j.ejca.2009.06.006.

引用本文的文献

1
Predicting the risk of bone metastases in patients with newly diagnosed prostate cancer - Development and validation of a nomogram model.预测新诊断前列腺癌患者发生骨转移的风险——列线图模型的构建与验证
PLoS One. 2025 Jan 30;20(1):e0318051. doi: 10.1371/journal.pone.0318051. eCollection 2025.
2
Nomograms to predict lung metastasis in malignant primary osseous spinal neoplasms and cancer-specific survival in lung metastasis subgroup.预测原发性恶性脊柱骨肿瘤肺转移及肺转移亚组癌症特异性生存率的列线图。
Front Oncol. 2024 Aug 20;14:1393990. doi: 10.3389/fonc.2024.1393990. eCollection 2024.
3
Antitumor Effect of Sclerostin against Osteosarcoma.
硬化蛋白对骨肉瘤的抗肿瘤作用
Cancers (Basel). 2021 Nov 29;13(23):6015. doi: 10.3390/cancers13236015.
4
Feasibility and safety of whole lung irradiation in the treatment of canine appendicular osteosarcoma.全肺照射治疗犬肢体骨肉瘤的可行性与安全性
Vet Comp Oncol. 2022 Mar;20(1):20-28. doi: 10.1111/vco.12702. Epub 2021 May 7.
5
Diffuse pleural metastases of osteosarcoma detected by bone scan.骨扫描检测到骨肉瘤的弥漫性胸膜转移。
World J Nucl Med. 2020 Aug 22;19(3):310-312. doi: 10.4103/wjnm.WJNM_59_20. eCollection 2020 Jul-Sep.
6
Risk factors for lung metastasis at presentation with malignant primary osseous neoplasms: a population-based study.恶性原发性骨肿瘤初诊时肺转移的危险因素:一项基于人群的研究。
J Orthop Surg Res. 2020 Jan 29;15(1):32. doi: 10.1186/s13018-020-1571-5.
7
Prognostic value of alkaline phosphatase in hormone-sensitive prostate cancer: a systematic review and meta-analysis.碱性磷酸酶在激素敏感型前列腺癌中的预后价值:系统评价和荟萃分析。
Int J Clin Oncol. 2020 Feb;25(2):247-257. doi: 10.1007/s10147-019-01578-9. Epub 2019 Nov 25.
8
Osteosarcoma presenting with malignant pleural effusion in a 55 year old.一名55岁患者的骨肉瘤伴恶性胸腔积液
Respir Med Case Rep. 2018 Oct 24;25:314-317. doi: 10.1016/j.rmcr.2018.10.017. eCollection 2018.
9
Meta-analysis of serum lactate dehydrogenase and prognosis for osteosarcoma.血清乳酸脱氢酶与骨肉瘤预后的Meta分析
Medicine (Baltimore). 2018 May;97(19):e0741. doi: 10.1097/MD.0000000000010741.
10
Osteosarcoma tissues and cell lines from patients with differing serum alkaline phosphatase concentrations display minimal differences in gene expression patterns.血清碱性磷酸酶浓度不同的骨肉瘤患者的组织和细胞系在基因表达模式上显示出极小的差异。
Vet Comp Oncol. 2016 Jun;14(2):e58-69. doi: 10.1111/vco.12132. Epub 2015 Feb 3.